Tayahop, Renita T.

HRN: 22-50-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/29/2023
02/04/2023
IV
1.5 Grams
Q 6 Hrs
Infected Wound
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes